We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Port Erin | LSE:PEBI | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.50 | 4.00 | 5.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMPEBI
RNS Number : 2409E
Port Erin Biopharma Investments Ltd
08 February 2018
For Immediate Release 7.00am 8 February 2018
Port Erin Biopharma Investments Limited
("Port Erin" or "the Company")
Appointment of Nominated Adviser and Broker
Port Erin is pleased to announce that it has today appointed Beaumont Cornish Limited as Nominated Adviser and Optiva Securities Limited as sole Broker to the Company with immediate effect.
For further information, please visit the Company's website: www.porterinbiopharma.com or contact: Port Erin Biopharma Investments Tel: +44 ( 0) 162 Limited 463 9396 Denham Eke Beaumont Cornish Limited Tel: +44 (0) 20 7628 Roland Cornish/ James 3396 Biddle Optiva Secuities Limited Tel: +44 (0) 203 137 Jeremy King/ Ed McDermott 1902
This information is provided by RNS
The company news service from the London Stock Exchange
END
APPBRGDDXBGBGIR
(END) Dow Jones Newswires
February 08, 2018 02:00 ET (07:00 GMT)
1 Year Port Erin Chart |
1 Month Port Erin Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
